According to the journal JAMA Health Forum, prescription fills for Ozempic increased by more than 400% between January 2021 ...
TikTok is full of wellness and health trends, and a leading doctor has shared his thoughts on the new 'Mounjaro drink' people ...
A new and surprising side effect from GLP-1 weight loss drugs is boosting business for plastic surgeons.Facial plastic ...
Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...
Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform consumers.
1h
Hosted on MSNUtah's slow (but steady) embrace of weight loss drugsUtah has one of the nation's lowest rates of prescriptions for anti-obesity GLP-1 drugs like Wegovy and Ozempic — but their ...
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...
Novo Nordisk shares tumbled last year when obesity candidate CagriSema failed to clear a weight loss bar of 25%. Now, ...
Recess Fitness Club launched Recess Rx for weight loss and wellness guidance.
Surgical tweaks for “Ozempic face” are on the rise. The latest report from AAFPRS reveals a 50% increase in facial fat ...
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.
New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results